The average selling price for VIDAS in Portugal dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the VIDAS device in Portugal can be viewed in GlobalData’s micro pricing report. Buy the report here.
The VIDAS is sold by bioMerieux Sa in the Procalcitonin Tests market. The procalcitonin (PCT) in vitro diagnostic device determines the quantity of PCT in the blood. Our blood typically contains relatively lower levels of PCT. However, PCT can be released into the bloodstream by cells in many different parts of the body in response to a major bacterial infection. A significant infection or sepsis may therefore be indicated by a high level of PCT in the blood. The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting PCT in patient samples. Other test types used to measure PCT include fluorescence immunoassays, latex enhanced immunoturbidimetric assays, and lateral flow immunochromatographic test strips.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.